Resistance training is associated with lower risk of type 2 diabetes
1. Resistance training among US adult health care professionals was associated with lower type 2 diabetes (T2D) risk, especially when ...
Tag: endocrinology
TikTok’s cortisol face trend meets endocrine reality
1. TikTok’s “cortisol face” trend has led more patients to request cortisol testing for facial puffiness, weight gain, or stress-related ...
Prednisone may have bone and cardiovascular benefits compared to hydrocortisone therapy in adrenal insufficiency
1. Prednisolone therapy is well tolerated, may have better bone and cardiovascular outcomes compared to hydrocortisone, and poses lower medication ...
Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
1. Retatrutide met all major Phase 3 endpoints, delivering substantial reductions in both A1C and body weight in patients with ...
Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders
1. Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US ...
Aerobic-resistance training and high-intensity interval training may improve metabolic and functional outcomes in adults with type 2 diabetes
1. 12 weeks of aerobic–resistance training and high-intensity interval training improved metabolic, functional, and quality-of-life outcomes in adults with type ...
Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer
1. In patients with ER-positive, HER2-negative advanced breast cancer who developed an ESR1 mutation during first-line aromatase inhibitor plus CDK4/6 ...
Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer
1. In this randomized controlled trial, vepdegestrant achieved a longer progression-free survival than fulvestrant in patients with advanced ER-positive, HER2-negative ...
Finerenone with empagliflozin beneficial for managing CKD and type 2 diabetes
1. Among patients with both chronic kidney disease (CKD) and type 2 diabetes (T2D) already on a renin-angiotensin system (RAS) ...
Weekly basal insulin efsitora effective for managing type 2 diabetes
1. In patients with type 2 diabetes mellitus (T2DM) who had not previously been on insulin therapy, once-weekly fixed-dose insulin ...
